Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1997-9-22 to 1997-10-17
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1997
Report date:
1997

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
no
GLP compliance:
yes
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
A guideline for LLNA was not available when the test was conducted.

Test material

Constituent 1
Chemical structure
Reference substance name:
N-(aminoiminomethyl)-N-methyl-Glycine, monohydrate
Cas Number:
6020-87-7
Molecular formula:
C4H9N3O2*H2O
IUPAC Name:
N-(aminoiminomethyl)-N-methyl-Glycine, monohydrate
Details on test material:
- Name of test material (as cited in study report): Creatine monohydrate
- Substance type: organic
- Physical state: slightly yellow solid
- Analytical purity: 101.1%
- Purity test date: 1997-11-26
- Lot/batch No.:725 201
- Expiration date of the lot/batch: 1998-9-15
- Stability under test conditions: at least 96 h
- Storage condition of test material: at room temperature in the dark

In vivo test system

Test animals

Species:
guinea pig
Strain:
Himalayan
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: BRL Ltd. Basel, Switzerland
- Age at study initiation: approx. 7 weeks old
- Weight at study initiation: group mean did not exceed 500 g
- Housing:
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period:

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 °C
- Humidity (%): 50 %
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
intradermal
Vehicle:
CMC (carboxymethyl cellulose)
Remarks:
(1 % aqueous carboxymethyl cellulose)
Concentration / amount:
Test substance concentrations selected for the main study were based on the results of a preliminary study.
In the main study, ten experimental animals were intradermally injected with a 2% concentration and epidermally exposed to a 50% concentration. Five control animals were similarly treated, but with the vehicle (1% Aqueous Carboxymethyl cellulose) only. Approximately 24 hours before the epidermal induction exposure all animals were treated with 10% SDS. Two weeks after the epidermal application all animals were challenged with a 50% test substance concentration and the vehicle.

Induction: intradermal injection 2 % (w/w); epidermal treatment with 50% (w/w)
Challenge: epidermal application of 50% test substance (0.5 ml)
Challengeopen allclose all
Route:
other: epidermal
Vehicle:
CMC (carboxymethyl cellulose)
Remarks:
(1 % aqueous carboxymethyl cellulose)
Concentration / amount:
Test substance concentrations selected for the main study were based on the results of a preliminary study.
In the main study, ten experimental animals were intradermally injected with a 2% concentration and epidermally exposed to a 50% concentration. Five control animals were similarly treated, but with the vehicle (1% Aqueous Carboxymethyl cellulose) only. Approximately 24 hours before the epidermal induction exposure all animals were treated with 10% SDS. Two weeks after the epidermal application all animals were challenged with a 50% test substance concentration and the vehicle.

Induction: intradermal injection 2 % (w/w); epidermal treatment with 50% (w/w)
Challenge: epidermal application of 50% test substance (0.5 ml)
No. of animals per dose:
10
Details on study design:
RANGE FINDING TESTS: selection of test substance concentrations suitable for induction and challenge;
Test concentrations: undiluted, 50%, 20%, 10%, 5%, 2%, 1%

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2
- Exposure period: day 1 to 8
- Test groups: 1 group consisting of 10 animals
- Control group: consisting of 5 animals; was treated as described for experimental animal, except that, instead of the test substance, the vehicle was administered
- Site: scapular region
- Duration: 8 days
- Concentrations: 2% and 50%

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 1 (on day day 21)
- Exposure period: 24 h
- Test groups: all animals
- Control group: consisting of 5 animals; was treated as described for experimental animals, except that, instead of the test substance, the vehicle was administered
- Site: scapular region
- Concentrations: 50%
- Evaluation (hr after challenge): 24 and 48 h
Challenge controls:
negative/vehicle control: instead of the test substance , the vehicle was administered
Positive control substance(s):
yes
Remarks:
alpha-hexylcinnamic aldehyde, tech. 85%

Results and discussion

Positive control results:
The sensitivity of female albino Himalayan guinea pigs to alpha-hexylcinnamicaldehyde, tech. 85% was checked. The experiments led to determination of a sensitisation rate of 100% to both the 10% and 5% concentrations of the substance.

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
72
Group:
negative control
Dose level:
vehicle
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
96
Group:
negative control
Dose level:
vehicle
No. with + reactions:
0
Total no. in group:
5
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
72
Group:
test chemical
Dose level:
50%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
96
Group:
test chemical
Dose level:
50%
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
no indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
10%
No. with + reactions:
10
Total no. in group:
10
Clinical observations:
score 2 and 3
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
10%
No. with + reactions:
10
Total no. in group:
10
Clinical observations:
score 2 and 3
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
5%
No. with + reactions:
10
Total no. in group:
10
Clinical observations:
score 2 and 3
Remarks on result:
positive indication of skin sensitisation
Key result
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
5%
No. with + reactions:
9
Total no. in group:
10
Clinical observations:
score 1, 2 and 3
Remarks on result:
positive indication of skin sensitisation

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In this study creatine monohydrate is not skin sensitizing
Executive summary:

In a dermal sensitization study based on OECD guideline No. 406 "Skin Sensitization (maximization test) creatine monohydrate in 1 % aqueous carboxymethyl cellulose was tested in female albino guinea pigs (Himalayan strain; approx. 7 weeks old; body weight mean < 500 g). A reliability check was carried out with alpha-hexylcinnamicaldehyde. No skin reactions were evident after the challenge exposure in the experimental and control animals. There was no evidence for skin hypersensitivity. A sensitization rate of 0% was determined. In this study creatine monohydrate is not a dermal sensitizer.